Israel Englander Verve Therapeutics, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,963,181 shares of VERV stock, worth $27.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,963,181
Previous 100,000
4863.18%
Holding current value
$27.8 Million
Previous $488,000
4822.34%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VERV
# of Institutions
186Shares Held
73.3MCall Options Held
85KPut Options Held
215K-
Alphabet Inc. Mountain View, CA12.3MShares$69.3 Million4.09% of portfolio
-
Black Rock Inc. New York, NY6.62MShares$37.1 Million0.0% of portfolio
-
State Street Corp Boston, MA4.25MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.01MShares$22.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY4MShares$22.4 Million1.5% of portfolio
About Verve Therapeutics, Inc.
- Ticker VERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,942,300
- Market Cap $336M
- Description
- Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...